• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外结石生成器中,草酸钙结石增大至具有临床意义的尺寸。

Enlargement of calcium oxalate stones to clinically significant size in an in-vitro stone generator.

作者信息

Ananth K, Kavanagh J P, Walton R C, Rao P N

机构信息

Lithotriptor Unit, South Manchester University Hospital Trust, Wythenshawe Hospital, Manchester, UK.

出版信息

BJU Int. 2002 Dec;90(9):939-44. doi: 10.1046/j.1464-410x.2002.03027.x.

DOI:10.1046/j.1464-410x.2002.03027.x
PMID:12460360
Abstract

OBJECTIVE

To develop and validate an in vitro method suitable for the quantitative investigation of the growth of calcium oxalate stones through to a clinically significant size.

MATERIALS AND METHODS

Small fragments of calcium oxalate calculi were suspended in a mixed suspension/mixed product removal crystalliser supplied with artificial urine supersaturated with calcium oxalate. The fragments were weighed at regular intervals until they reached approximately equal 500 mg. The results were plotted as weight against time and fitted to equations corresponding to constant increase in diameter, surface area-controlled and constant-deposition growth patterns. The choice of the most appropriate model was based on the squared regression coefficient (r2).

RESULTS

Eight fragments (2-6 mm in diameter) were grown to approximately 10 mm in diameter over periods from 137 to 369 h. Seven of the growth curves were best-fitted (r2 > or = 0.988) by the equation w = kt(3/2) + c, where w is the weight, k is a growth constant, t is the time and c is a constant approximating to the initial weight. This corresponds to a surface area-dependent mechanism.

CONCLUSIONS

The growth of these small fragments to a clinically significant size accelerated throughout the experimental period in a way which was consistent with a surface area-dependent mechanism. We have developed a resilient model suitable for studying the kinetics of calcium oxalate stone growth in vitro.

摘要

目的

开发并验证一种体外方法,该方法适用于对草酸钙结石生长至具有临床意义大小的过程进行定量研究。

材料与方法

将草酸钙结石的小碎片悬浮于配备有草酸钙过饱和人工尿液的混合悬浮液/混合产物移除结晶器中。定期对碎片称重,直至其重量达到约500毫克左右。将结果绘制成重量对时间的曲线,并拟合对应于直径持续增加、表面积控制和恒定沉积生长模式的方程。基于平方回归系数(r²)来选择最合适的模型。

结果

八个碎片(直径2 - 6毫米)在137至369小时的时间段内生长至直径约10毫米。七条生长曲线最适合(r²≥0.988)的方程为w = kt^(3/2) + c,其中w为重量,k为生长常数,t为时间,c为近似初始重量的常数。这对应于一种依赖表面积的机制。

结论

在整个实验期间,这些小碎片生长至具有临床意义大小的过程加速,其方式与依赖表面积的机制一致。我们开发了一种适用于研究体外草酸钙结石生长动力学的可靠模型。

相似文献

1
Enlargement of calcium oxalate stones to clinically significant size in an in-vitro stone generator.在体外结石生成器中,草酸钙结石增大至具有临床意义的尺寸。
BJU Int. 2002 Dec;90(9):939-44. doi: 10.1046/j.1464-410x.2002.03027.x.
2
Enlargement of a lower pole calcium oxalate stone: a theoretical examination of the role of crystal nucleation, growth, and aggregation.
J Endourol. 1999 Nov;13(9):605-10. doi: 10.1089/end.1999.13.605.
3
Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.白蛋白介导的草酸钙晶体成核作用:对预防结石形成的影响。
Kidney Int. 1999 May;55(5):1776-86. doi: 10.1046/j.1523-1755.1999.00426.x.
4
A stone farm: development of a method for simultaneous production of multiple calcium oxalate stones in vitro.结石养殖场:体外同时生成多种草酸钙结石方法的研发
Urol Res. 2004 Feb;32(1):55-60. doi: 10.1007/s00240-003-0379-1. Epub 2003 Oct 22.
5
Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization.氨苯蝶啶与肾结石形成:氨苯蝶啶及氨苯蝶啶结石对草酸钙结晶的影响
Calcif Tissue Int. 1987 Feb;40(2):79-84. doi: 10.1007/BF02555709.
6
Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones.在草酸钙肾结石的体外模型中,柠檬酸盐可抑制残余碎片的生长。
Kidney Int. 2004 May;65(5):1724-30. doi: 10.1111/j.1523-1755.2004.00566.x.
7
A nidus, crystalluria and aggregation: key ingredients for stone enlargement.核心、结晶尿和聚集:结石增大的关键因素。
Urol Res. 2008 Feb;36(1):11-5. doi: 10.1007/s00240-007-0121-5. Epub 2007 Nov 20.
8
Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.影响二水合草酸钙碎结石再生长的因素。
BMC Urol. 2006 Jul 5;6:16. doi: 10.1186/1471-2490-6-16.
9
Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.晶体表面粘附解释了水合草酸钙在肾结石形成中的病理活性。
J Am Soc Nephrol. 2005 Jul;16(7):1904-8. doi: 10.1681/ASN.2005040400. Epub 2005 Jun 1.
10
The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.在人工尿液中,骨桥蛋白控制一水草酸钙单水合物形态的转变,为研究乳头状肾结石的形成提供了思路。
Colloids Surf B Biointerfaces. 2016 Oct 1;146:296-306. doi: 10.1016/j.colsurfb.2016.06.030. Epub 2016 Jun 16.

引用本文的文献

1
Diffusion-driven growth of calcium carbonate polymorphs in microchannels.微通道中碳酸钙多晶型物的扩散驱动生长
RSC Adv. 2024 Dec 17;14(53):39618-39624. doi: 10.1039/d4ra07137a. eCollection 2024 Dec 10.
2
Urinary Stent Development and Evaluation Models: In Vitro, Ex Vivo and In Vivo-A European Network of Multidisciplinary Research to Improve Urinary Stents (ENIUS) Initiative.尿支架开发与评估模型:体外、离体和体内——欧洲改善尿支架多学科研究网络(ENIUS)倡议
Polymers (Basel). 2022 Apr 19;14(9):1641. doi: 10.3390/polym14091641.
3
Demineralization and sectioning of human kidney stones: A molecular investigation revealing the spatial heterogeneity of the stone matrix.
人肾结石的脱矿和切片:揭示结石基质空间异质性的分子研究。
Physiol Rep. 2021 Jan;9(1):e14658. doi: 10.14814/phy2.14658.
4
A nidus, crystalluria and aggregation: key ingredients for stone enlargement.核心、结晶尿和聚集:结石增大的关键因素。
Urol Res. 2008 Feb;36(1):11-5. doi: 10.1007/s00240-007-0121-5. Epub 2007 Nov 20.
5
Supersaturation and renal precipitation: the key to stone formation?过饱和与肾脏沉淀:结石形成的关键?
Urol Res. 2006 Apr;34(2):81-5. doi: 10.1007/s00240-005-0015-3. Epub 2006 Jan 26.
6
In vitro calcium oxalate crystallisation methods.体外草酸钙结晶方法。
Urol Res. 2006 Apr;34(2):139-45. doi: 10.1007/s00240-005-0027-z. Epub 2006 Jan 14.